KaydedilenlerDerginizi ekleyin

Dergiler / The Anatolian Journal of Cardiology / 2021 / Cilt: 25 - Sayı: 4

Primary patency and amputation free survival after endovascular management of infrarenal aorta total occlusions

Ender Özgün ÇAKMAK
Münevver SARI
Zeki ŞİMŞEK
Şeyhmus KÜLAHÇIOĞLU
Ali KARAGÖZ
Çetin GEÇMEN
Çağrı KAFKAS
İbrahim Akın İZGİ
Cevat KİRMA
Sayfa
258–265
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

None of the demographic, lesion, and device factors were independently associated with loss of primary patency.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Endovascular therapy (EVT) has increasingly been used even after the development of new techniques and technologies.
📊
Temel Bulgular & Veri:Nonetheless, little is known regarding their long-term outcomes and predictors of restenosis.Methods: A total of 55 consecutive patients (age, 58.8±6.97 years; 67.2% male; 42% critical limb ischemia) from a single-center database, under-going EVT for IAO disease between January 2011 and March 2019 were retrospectively analyzed.
💡
Sonuç & Katkı:None of the demographic, lesion, and device factors were independently associated with loss of primary patency.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Endovascular therapy (EVT) has increasingly been used even after the development of new techniques and technologies. EVT has displayed durable early and mid-term outcomes for infrarenal aorta occlusions (IAO). Nonetheless, little is known regarding their long-term outcomes and predictors of restenosis.Methods: A total of 55 consecutive patients (age, 58.8±6.97 years; 67.2% male; 42% critical limb ischemia) from a single-center database, under-going EVT for IAO disease between January 2011 and March 2019 were retrospectively analyzed. The outcome measures were primary patency rate and amputation free survival calculated by the Kaplan–Meier method. Independent predictors of restenosis were assessed by Cox propor-tional hazard regression model.Results: In 49 patients (89.1%), technical success was achieved. In total, 190 stents (65 self-expandable stents, 60 balloon-expandable stents) were implanted. During the follow up of 34.5±28 months, 7 patients experienced loss of patency. Primary patency rates were 96%, 82%, and 75% at 1, 3, and 5 years, respectively, and amputation free survival rates were 100%, 90%, and 82% at 1, 3, and 5 years, respectively.Conclusion: In this study, five-year outcomes of primary patency and amputation free survival for EVT of infrarenal aorta total occlusive lesions were favorable. None of the demographic, lesion, and device factors were independently associated with loss of primary patency.

🔖

Bu Makaleye Atıf Yap

ÇAKMAK, E. Ö., SARI, M., ŞİMŞEK, Z., KÜLAHÇIOĞLU, Ş., KARAGÖZ, A., GEÇMEN, Ç., KAFKAS, Ç., İZGİ, İ. A., KİRMA, C. (2021). Primary patency and amputation free survival after endovascular management of infrarenal aorta total occlusions. The Anatolian Journal of Cardiology, Cilt: 25 - Sayı: 4, 258–265. https://ajindex.com/articles/365094

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Leriche R. High arterial obliterations (obliteration of the termination of the aorta) as a cause of circulatory insufficiency in the lower limbs. Bull Mem Soc Chir 1923; 49: 1401-6
  2. Casali RE, Tucker E, Read RC, Thompson BW. Total infrarenal aortic occlusion. Am J Surg 1977; 134: 809–1
  3. Madiba TE, Robbs JV. Aortofemoral bypass in the presence of total juxtarenal aortic occlusion. Eur J Vasc Surg 1993; 7: 77–81
  4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Man-agement of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S: S5–67
  5. Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010; 52: 1376–83
  6. Rzucidlo EM, Powell RJ, Zwolak RM, Fillinger MF, Walsh DB, Schermerhorn ML, et al. Early results of stent-grafting to treat dif-fuse aortoiliac occlusive disease. J Vasc Surg 2003; 37: 1175–80. 7. d'Othée BJ, Haulon S, Mounier-Vehier C, Beregi JP, Jabourek O, Willoteaux S. Percutaneous endovascular treatment for stenoses and occlusions of infrarenal aorta and aortoiliac bifurcation: mid-term results. Eur J Vasc Endovasc Surg 2002; 24: 516–23
  7. Moise MA, Alvarez-Tostado JA, Clair DG, Greenberg RK, Lyden SP, Srivastava SD, et al. Endovascular management of chronic infrare-nal aortic occlusion. J Endovasc Ther 2009; 16: 84–92
  8. Krankenberg H, Schlüter M, Schwencke C, Walter D, Pascotto A, Sandstede J, et al. Endovascular reconstruction of the aortic bifurcation in patients with Leriche syndrome. Clin Res Cardiol 2009; 98: 657–64
  9. Kim TH, Ko YG, Kim U, Kim JS, Choi D, Hong MK, et al. Outcomes of endovascular treatment of chronic total occlusion of the infrarenal aorta. J Vasc Surg 2011; 53: 1542–9
  10. Nanto K, Iida O, Fujihara M, Yokoi Y, Tomoi Y, Soga Y, et al. Five-Year Patency and its Predictors after Endovascular Therapy for Aortoili-ac Occlusive Disease. J Atheroscler Thromb 2019; 26: 989–96. 12. de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aor-toiliac occlusive disease: a meta-analysis. J Vasc Surg 1997; 26: 558–69
  11. Mousa AY, Beauford RB, Flores L, Faries PL, Patel P, Fogler R. Endo-vascular treatment of iliac occlusive disease: review and update. Vascular 2007; 15: 5–11
  12. Leu AJ, Schneider E, Canova CR, Hoffmann U. Long-term results after recanalisation of chronic iliac artery occlusions by combined catheter therapy w